Generalized anxiety disorder: A comorbid disease

European Neuropsychopharmacology

Volumn 16, Issue SUPPL. 2, 2006, Pages

  Nutt, David ^a   Argyropoulos, Spilos ^a   Hood, Sean ^a   Potokar, John ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Burden; Comorbidity; Diagnosis; Generalized anxiety disorder; Neurobiologic mechanisms; Prevalence

Indexed keywords

ALPRAZOLAM; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE; BENZODIAZEPINE RECEPTOR; FLUOXETINE; MIRTAZAPINE; MOCLOBEMIDE; NORADRENALIN UPTAKE INHIBITOR; NORTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TRYPTOPHAN; VENLAFAXINE;

ARTICLE; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; GABAERGIC SYSTEM; GENERALIZED ANXIETY DISORDER; HUMAN; MONITORING; NAUSEA; NEUROBIOLOGY; OUTCOME ASSESSMENT; PHYSICIAN; POLYPHARMACY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RATING SCALE; SELF CONCEPT; SEROTONINERGIC SYSTEM; SEXUAL DYSFUNCTION; SUICIDAL BEHAVIOR; SYMPTOM;

AGORAPHOBIA; ANTI-ANXIETY AGENTS; COMORBIDITY; COST OF ILLNESS; HUMANS; MENTAL DISORDERS; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, GABA-A; TRYPTOPHAN;

EID: 33745369856     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2006.04.003     Document Type: Article

References (80)

1. Allgulander C., and Lavori P.W. Causes of death among 936 elderly patients with 'pure' anxiety neurosis in Stockholm County, Sweden, and in patients with depressive neurosis or both diagnoses. Compr. Psychiatry 34 (1993) 299-302
2. Argyropoulos S., Wright T., Forshall S., and Nutt D. Generalized Anxiety Disorder Inventory (GADI): development and validation of a new questionnaire. J. Psychopharmacol. Suppl. 15[3] (2001) A21
3. Argyropoulos S.V., Hood S.D., Adrover M., Bell C.J., Rich A.S., Nash J.R., Rich N.C., Witchel H.J., and Nutt D.J. Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder. Biol. Psychiatry 56 (2004) 503-509
4. Bakish D. The patient with comorbid depression and anxiety: the unmet need. J. Clin. Psychiatry 60 Suppl. 6 (1999) 20-24
5. Ballenger J.C. Current treatments of the anxiety disorders in adults. Biol. Psychiatry 46 (1999) 1579-1594
6. Barr L.C., Goodman W.K., McDougle C.J., Delgado P.L., Heninger G.R., Charney S., and Price L.H. Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors. Arch. Gen. Psychiatry 51 (1994) 309-317
7. Barr L.C., Heninger G.R., Goodman W., Charney D.S., and Price L.H. Effects of fluoxetine administration on mood response to tryptophan depletion in healthy subjects. Biol. Psychiatry 41 (1997) 949-954
8. Belanger L., Morin C.M., Langlois F., and Ladouceur R. Insomnia and generalized anxiety disorder: effects of cognitive behavior therapy for gad on insomnia symptoms. J. Anxiety Disord. 18 (2004) 561-571
9. Bell C., Abrams J., and Nutt D. Tryptophan depletion and its implications for psychiatry. Br. J. Psychiatry 178 (2001) 399-405
10. Bell C., Forshall S., Adrover M., Nash J., Hood S., Argyropoulos S., Rich A., and Nutt D.J. Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine. J. Psychopharmacol. 16 (2002) 5-14
11. Bensenor I.M., Tofoli L.F., and Andrade L. Headache complaints associated with psychiatric comorbidity in a population-based sample. Braz. J. Med. Biol. Res. 36 (2003) 1425-1432
12. Bland R.C., Newman S.C., and Orn H. Help-seeking for psychiatric disorders. Can. J. Psychiatry 42 (1997) 935-942
13. Borkovec T.D., Abel J.L., and Newman H. Effects of psychotherapy on comorbid conditions in generalized anxiety disorder. J. Consult. Clin. Psychol. 63 (1995) 479-483
14. Brawman-Mintzer O., Lydiard R.B., Emmanuel N., Payeur R., Johnson M., Roberts J., Jarrell M.P., and Ballenger J.C. Psychiatric comorbidity in patients with generalized anxiety disorder. Am. J. Psychiatry 150 (1993) 1216-1218
15. Brenes G.A. Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment. Psychosom. Med. 65 (2003) 963-970
16. Bruce S.E., Machan J.T., Dyck I., and Keller M.B. Infrequency of "pure" GAD: impact of psychiatric comorbidity on clinical course. Depress. Anxiety 14 (2001) 219-225
17. Carter R.M., Wittchen H.U., Pfister H., and Kessler R.C. One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample. Depress. Anxiety 13 (2001) 78-88
18. Cassano G.B., Perugi G., and Musetti L. Comorbidity in panic disorder. Psychiatr. Ann. 20 (1990) 517-521
19. Connor K.M., Davidson J.R., Churchill L.E., Sherwood A., Foa E., and Weisler R.H. Psychometric properties of the Social Phobia Inventory (SPIN). New self-rating scale. Br. J. Psychiatry 176 (2000) 379-386
20. De Cristofaro M.T., Sessarego A., Pupi A., Biondi F., and Faravelli C. Brain perfusion abnormalities in drug-naive, lactate-sensitive panic patients: a SPECT study. Biol. Psychiatry 33 (1993) 505-512
21. Delgado P.L., Miller H.L., Salomon R.M., Licinio J., Krystal J.H., Moreno F.A., Heninger G.R., and Charney D.S. Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action. Biol. Psychiatry 46 (1999) 212-220
22. Fava M., Rankin M.A., Wright E.C., Alpert J.E., Nierenberg A.A., Pava J., and Rosenbaum J.F. Anxiety disorders in major depression. Compr. Psychiatry 41 (2000) 97-102
23. Flint A.J. Epidemiology and comorbidity of anxiety disorders in the elderly. Am. J. Psychiatry 151 (1994) 640-649
24. Garyfallos G., Adamopoulou A., Karastergiou A., Voikli M., Milis V., Donias S., Giouzepas J., and Parashos A. Psychiatric comorbidity in Greek patients with generalized anxiety disorder. Psychopathology 32 (1999) 308-318
25. Goisman R.M., Goldenberg I., Vasile R.G., and Keller M.B. Comorbidity of anxiety disorders in a multicenter anxiety study. Compr. Psychiatry 36 (1995) 303-311
26. Goodnick P.J., Puig A., DeVane C.L., and Freund B.V. Mirtazapine in major depression with comorbid generalized anxiety disorder. J. Clin. Psychiatry 60 (1999) 446-448
27. Grothe D.R., Scheckner B., and Albano D. Treatment of pain syndromes with venlafaxine. Pharmacotherapy 24 (2004) 621-629
28. Johnson M.R., and Lydiard R.B. The neurobiology of anxiety disorders. In: Pollack M.H., and Otto M. (Eds). Psychiatric Clinics of North America (1995), W.B. Saunders, Philadelphia, PA 681-725
29. Jorge R.E., Leston J.E., Arndt S., and Robinson R.G. Cluster headaches: association with anxiety disorders and memory deficits. Neurology 53 (1999) 543-547
30. Juang K.D., Wang S.J., Fuh J.L., Lu S.R., and Su T.P. Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes. Headache 40 (2000) 818-823
31. Judd L.L., Kessler R.C., Paulus M.P., Zeller P.V., Wittchen H.U., and Kunovac J.L. Comorbidity as a fundamental feature of generalized anxiety disorders: results from the National Comorbidity Study (NCS). Acta Psychiatr. Scand., Suppl. 393 (1998) 6-11
32. Kaufman J., and Charney D. Comorbidity of mood and anxiety disorders. Depress. Anxiety 12 Suppl. 1 (2000) 69-76
33. Kaye W.H., Gendall K.A., Fernstrom M.H., Fernstrom J.D., McConaha C.W., and Weltzin T.E. Effects of acute tryptophan depletion on mood in bulimia nervosa. Biol. Psychiatry 47 (2000) 151-157
34. Kessler R.C. The epidemiology of pure and comorbid generalized anxiety disorder: a review and evaluation of recent research. Acta Psychiatr. Scand., Suppl. (2000) 7-13
35. Kessler R.C., DuPont R.L., Berglund P., and Wittchen H.U. Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys. Am. J. Psychiatry 156 (1999) 1915-1923
36. Kessler R.C., Keller M.B., and Wittchen H.U. The epidemiology of generalized anxiety disorder. Psychiatr. Clin. North Am. 24 (2001) 19-39
37. Kimura M., Tateno A., and Robinson R.G. Treatment of poststroke generalized anxiety disorder comorbid with poststroke depression: merged analysis of nortriptyline trials. Am. J. Geriatr. Psychiatry 11 (2003) 320-327
38. Krasucki C., Howard R., and Mann A. The relationship between anxiety disorders and age. Int. J. Geriatr. Psychiatry 13 (1998) 79-99
39. Lader M.H. Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?. Eur. Neuropsychopharmacol. 9 Suppl. 6 (1999) S399-S405
40. Maier W., Gansicke M., Freyberger H.J., Linz M., Heun R., and Lecrubier Y. Generalized anxiety disorder (ICD-10) in primary care from a cross-cultural perspective: a valid diagnostic entity?. Acta Psychiatr. Scand. 101 (2000) 29-36
41. Malizia A.L., Cunningham V.J., Bell C.J., Liddle P.F., Jones T., and Nutt D.J. Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. Arch. Gen. Psychiatry 55 (1998) 715-720
42. Masi G., Mucci M., Favilla L., and Millepiedi S. Anxiety comorbidity in referred children and adolescents with dysthymic disorder. Psychopathology 34 (2001) 253-258
43. Masi G., Millepiedi S., Mucci M., Poli P., Bertini N., and Milantoni L. Generalized anxiety disorder in referred children and adolescents. J. Am. Acad. Child Adolesc. Psych. 43 (2004) 752-760
44. Massion A.O., Warshaw M.G., and Keller M.B. Quality of life and psychiatric morbidity in panic disorder and generalized anxiety disorder. Am. J. Psychiatry 150 (1993) 600-607
45. McWilliams L.A., Cox B.J., and Enns M.W. Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample. Pain 106 (2003) 127-133
46. Mennin D.S., Heimberg R.G., and Jack M.S. Comorbid generalized anxiety disorder in primary social phobia: symptom severity, functional impairment, and treatment response. J. Anxiety Disord. 14 (2000) 325-343
47. Monti J.M., and Monti D. Sleep disturbance in generalized anxiety disorder and its treatment. Sleep Med. Rev. 4 (2000) 263-276
48. Ninan P.T. Dissolving the burden of generalized anxiety disorder. J. Clin. Psychiatry 62 Suppl. 19 (2001) 5-10
49. Nordahl T.E., Semple W.E., Gross M., Mellman T.A., Stein M.B., Goyer P., King A.C., Uhde T.W., and Cohen R.M. Cerebral glucose metabolic differences in patients with panic disorder. Neuropsychopharmacology 3 (1990) 261-272
50. Noyes Jr. R. Comorbidity in generalized anxiety disorder. Psychiatr. Clin. North Am. 24 (2001) 41-55
51. Ormel J., VonKorff M., Ustun T.B., Pini S., Korten A., and Oldehinkel T. Common mental disorders and disability across cultures. Results from the WHO Collaborative Study on Psychological Problems in General Health Care. JAMA 272 (1994) 1741-1748
52. Perugi G., Frare F., Toni C., Ruffolo G., and Torti C. Open-label evaluation of venlafaxine sustained release in outpatients with generalized anxiety disorder with comorbid major depression or dysthymia: effectiveness, tolerability and predictors of response. Neuropsychobiology 46 (2002) 145-149
53. Pini S., Amador X.F., Dell'Osso L., Baldini Rossi N., Cassano P., Savino M., and Cassano G.B. Treatment of depression with comorbid anxiety disorders: differential efficacy of paroxetine versus moclobemide. Int. Clin. Psychopharmacol. 18 (2003) 15-21
54. Porter R.J., Lunn B.S., and O'Brien J.T. Effects of acute tryptophan depletion on cognitive function in Alzheimer's disease and in the healthy elderly. Psychol. Med. 33 (2003) 41-49
55. Puca F., Genco S., Prudenzano M.P., Savarese M., Bussone G., D'Amico D., Cerbo R., Gala C., Coppola M.T., Gallai V., Firenze C., Sarchielli P., Guazzelli M., Guidetti V., Manzoni G., Granella F., Muratorio A., Bonuccelli U., Nuti A., Nappi G., Sandrini G., Verri A.P., Sicuteri F., and Marabini S. Psychiatric comorbidity and psychosocial stress in patients with tension-type headache from headache centers in Italy. The Italian Collaborative Group for the Study of Psychopathological Factors in Primary Headaches. Cephalalgia 19 (1999) 159-164
56. Rauch S.L., van der Kolk B.A., Fisler R.E., Alpert N.M., Orr S.P., Savage C.R., Fischman A.J., Jenike M.A., and Pitman R.K. A symptom provocation study of posttraumatic stress disorder using positron emission tomography and script-driven imagery. Arch. Gen. Psychiatry 53 (1996) 380-387
57. Reilly J.G., McTavish S.F., and Young A.H. Rapid depletion of plasma tryptophan: a review of studies and experimental methodology. J. Psychopharmacol. 11 (1997) 381-392
58. Roy-Byrne P.P. Generalized anxiety and mixed anxiety-depression: association with disability and health care utilization. J. Clin. Psychiatry 57 Suppl. 7 (1996) 86-91
59. Rudd M.D., Dahm P.F., and Rajab M.H. Diagnostic comorbidity in persons with suicidal ideation and behavior. Am. J. Psychiatry 150 (1993) 928-934
60. Sanderson W.C., Wetzler S., Beck A.T., and Betz F. Prevalence of personality disorders among patients with anxiety disorders. Psychiatry Res. 51 (1994) 167-174
61. Schoevers R.A., Beekman A.T., Deeg D.J., Jonker C., and van Tilburg W. Comorbidity and risk-patterns of depression, generalised anxiety disorder and mixed anxiety-depression in later life: results from the AMSTEL study. Int. J. Geriatr. Psychiatry 18 (2003) 994-1001
62. Sheftell F.D., and Atlas S.J. Migraine and psychiatric comorbidity: from theory and hypotheses to clinical application. Headache 42 (2002) 934-944
63. Sherbourne C.D., and Wells K.B. Course of depression in patients with comorbid anxiety disorders. J. Affect. Disord. 43 (1997) 245-250
64. Sherbourne C.D., Wells K.B., Meredith L.S., Jackson C.A., and Camp P. Comorbid anxiety disorder and the functioning and well-being of chronically ill patients of general medical providers. Arch. Gen. Psychiatry 53 (1996) 889-895
65. Silverstone P.H., and Salinas E. Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder. J. Clin. Psychiatry 62 (2001) 523-529
66. Smith K.A., Fairburn C.G., and Cowen P.J. Relapse of depression after rapid depletion of tryptophan. Lancet 349 (1997) 915-919
67. Souetre E., Lozet H., Cimarosti I., Martin P., Chignon J.M., Ades J., Tignol J., and Darcourt G. Cost of anxiety disorders: impact of comorbidity. J. Psychosom. Res. 38 Suppl. 1 (1994) 151-160
68. Stein D.J. Comorbidity in generalized anxiety disorder: impact and implications. J. Clin. Psychiatry 62 Suppl. 11 (2001) 29-34
69. Stein M.B., McQuaid J.R., Pedrelli P., Lenox R., and McCahill M.E. Posttraumatic stress disorder in the primary care medical setting. Gen. Hosp. Psych. 22 (2000) 261-269
70. Tiihonen J., Kuikka J., Rasanen P., Lepola U., Koponen H., Liuska A., Lehmusvaara A., Vainio P., Kononen M., Bergstrom K., Yu M., Kinnunen I., Akerman K., and Karhu J. Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder: a fractal analysis. Mol. Psychiatry 2 (1997) 463-471
71. Tollefson G.D., Luxenberg M., Valentine R., Dunsmore G., and Tollefson G. An open label trial of alprazolam in comorbid irritable bowel syndrome and generalized anxiety disorder. J. Clin. Psychiatry 52 (1991) 502-508
72. Tsao J.C., Lewin M.R., and Craske M.G. The effects of cognitive-behavior therapy for panic disorder on comorbid conditions. J. Anxiety Disord. 12 (1998) 357-371
73. Wagner K.D. Generalized anxiety disorder in children and adolescents. Psychiatr. Clin. North Am. 24 (2001) 139-153
74. Wittchen H.U., Zhao S., Kessler R.C., and Eaton W.W. DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Arch. Gen. Psychiatry 51 (1994) 355-364
75. Wittchen H.U., Carter R.M., Pfister H., Montgomery S.A., and Kessler R.C. Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey. Int. Clin. Psychopharmacol. 15 (2000) 319-328
76. Wittchen H.U., Kessler R.C., Beesdo K., Krause P., Hofler M., and Hoyer J. Generalized anxiety and depression in primary care: prevalence, recognition, and management. J. Clin. Psychiatry 63 Suppl. 8 (2002) 24-34
77. Wu J.C., Buchsbaum M.S., Hershey T.G., Hazlett E., Sicotte N., and Johnson J.C. PET in generalized anxiety disorder. Biol. Psychiatry 29 (1991) 1181-1199
78. Yonkers K.A., Warshaw M.G., Massion A.O., and Keller M.B. Phenomenology and course of generalised anxiety disorder. Br. J. Psychiatry 168 (1996) 308-313
79. Yonkers K.A., Dyck I.R., Warshaw M., and Keller M.B. Factors predicting the clinical course of generalised anxiety disorder. Br. J. Psychiatry 176 (2000) 544-549
80. Zwart J.A., Dyb G., Hagen K., Odegard K.J., Dahl A.A., Bovim G., and Stovner L.J. Depression and anxiety disorders associated with headache frequency. The Nord-Trondelag Health Study. Eur. J. Neurol. 10 (2003) 147-152